Tumor screening
Contact Us
CanAg Diagnostics (Beijing) Co., Ltd.
Room 1151, Hotel Nikko New Century Beijing Office Tower Building,
No.6 Southern Road Capital Gym, Haidian District, Beijing, China
Post code: 100044
Tel: +86 10 8528 8156 68492672
Fax: +86 10 8528 8382
E-mail :canag@canag.com.cn
Mobile Phone:17896035653
logistics Department
Tel: +86 10 88431258/2778/2621
Fax: +86 10 88434018
E-mail:order@canag.com.cn
Tumor markers are important indicators of tumor-assisted diagnosis,
prognosis, efficacy observation and relapse detection. It is mainly used for
the diagnosis of tumor. It can not be diagnosed by tumor markers (or elevation)
alone.
As the current commonly used tumor markers in the diagnosis of malignant
tumors when the sensitivity and specificity are not high enough, the same tumor
or different types of tumors may have one or more tumor marker concentration
abnormalities, the same tumor markers can appear in different tumors The In
order to improve the diagnostic value of tumor markers and determine which
markers to be used as follow-up monitoring indicators after treatment, joint
testing can be carried out, but the indicators of joint detection must be scientifically
analyzed and strictly screened. In the above premise, a reasonable choice of
2-3 high sensitivity and specificity of the relatively good TM joint detection,
effectively improve the detection accuracy at the same time, reduce the
patient's economic pressure.
The optimal combination of CanAg tumor markers detection of recommended:
Types
of cancer |
The
optimal tumor marker combination |
Lung
cancer |
CYFRA21-1、SCC、CEA、ProGRP、NSE |
Ovarian
cancer |
HE4、CA125 |
Pancreatic
cancer |
CA19-9、CA242 |
Colorectal
cancer |
CEA、CA19-9、CA242 |
Prostatic
cancer |
PSA、F-PSA |
Liver
cancer |
AFP |
Breast
cancer |
CA15-3、CEA |
Gastric
cancer |
CA72-4、CEA、CA19-9 |
Cervical
cancer |
SCC、CEA |